MetaADEDB 2.0 @ LMMD
Nicergoline
(YSEXMKHXIOCEJA-FVFQAYNVSA-N)
Structure
SMILES
CO[C@]12C[C@@H](COC(=O)c3cncc(c3)Br)CN([C@@H]1Cc1c3c2cccc3n(c1)C)C
Type(s)
Approved; Investigational
ATC code(s)
C04AE02
Molecular Formula:
C24H26BrN3O3
Molecular Weight:
484.386
Log P:
3.8488
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
0
TPSA:
56.59
CAS Number(s):
27848-84-6
Synonym(s)
1.
Nicergoline
2.
Nimergoline
3.
Circo-Maren
4.
Ergobel
5.
F.I. 6714
6.
Fisifax
7.
Nicergobeta
8.
Nicergolin Atid
9.
Nicergolin Lindo
10.
Nicergolin Von Ct
11.
Nicergolin-Neuraxpharm
12.
Nicergolin-Ratiopharm
13.
Nicergolin-TEVA
14.
Nicerium
15.
Nicotergoline
16.
Sermion
17.
Circo Maren
18.
Nicergolin Neuraxpharm
19.
Nicergolin Ratiopharm
20.
Nicergolin TEVA
21.
Von Ct, Nicergolin
External Link(s)
MeSHD009530
PubChem Compound34040
ChEBI31902
CHEMBLCHEMBL1372950
DrugBankDB00699
DrugCentral1910
KEGGdr:D01290
Therapeutic Target DatabaseD0V2GH
ZINC3873817
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2AbuliaOFFSIDES
3Acute Coronary SyndromeOFFSIDES
4Acute myocardial infarctionOFFSIDES
5Adverse eventOFFSIDES
6Alanine Aminotransferase IncreasedOFFSIDES
7Altered bowel functionOFFSIDES
8Altered state of consciousnessOFFSIDES
9AlveolitisOFFSIDES
10Amnesia2571367
3419247
CTD
11Ankle FractureOFFSIDES
12AnorexiaOFFSIDES
13Arteritis6270809CTD
14Arthralgia12372954CTD
15AsbestosisOFFSIDES
16Aspiration PneumoniaOFFSIDES
17Beta-N-acetyl-D-glucosaminidase increasedOFFSIDES
18Blood creatine increasedOFFSIDES
19Blood creatine phosphokinase increasedOFFSIDES
20Blood creatinine increasedOFFSIDES
21Blood glucose abnormalOFFSIDES
22Blood lactate dehydrogenase increasedOFFSIDES
23Blood osmolarity decreasedOFFSIDES
24Blood phosphorus increasedOFFSIDES
25Blood potassium increasedOFFSIDES
26Blood sodium abnormalOFFSIDES
27Blood sodiumOFFSIDES
28Blood urea abnormalOFFSIDES
29Blood urea increasedOFFSIDES
30Bone painOFFSIDES
31Bradycardia3012204
4085539
CTD
OFFSIDES
32Cataract operationOFFSIDES
33CataractOFFSIDES
34Cerebellar AtaxiaOFFSIDES
35Cerebral circulatory failureOFFSIDES
36Chemotherapeutic drug level increasedOFFSIDES
37Chest Pain15222138CTD
38Cognitive deteriorationOFFSIDES
39ConfabulationOFFSIDES
40Cytolytic hepatitisOFFSIDES
41Depressed Level of ConsciousnessOFFSIDES
42Disease recurrenceOFFSIDES
43Disseminated Intravascular CoagulationOFFSIDES
44DiverticulosisOFFSIDES
45DrowsinessOFFSIDES
46DyscheziaOFFSIDES
47EczemaOFFSIDES
48EnterocolitisOFFSIDES
49Eosinophilia12372954CTD
50EpilepsyOFFSIDES
51Epstein-Barr virus test positiveOFFSIDES
52ErythemaOFFSIDES
53Fever12372954CTD
54Gamma-Glutamyltransferase IncreasedOFFSIDES
55Glomerular vascular disorderOFFSIDES
56Headache15222138CTD
57HemiparesisOFFSIDES
58HemiplegiaOFFSIDES
59Histiocytosis haematophagicOFFSIDES
60HyperparathyroidismOFFSIDES
61HypokinesiaOFFSIDES
62HypophagiaOFFSIDES
63Hypotension

View details

CTD
64IncontinenceOFFSIDES
65Intraoperative Complications4092160CTD
66IridocyclitisOFFSIDES
67Large intestine perforationOFFSIDES
68Leukopenia neonatalOFFSIDES
69Mental impairmentOFFSIDES
70Myoclonus37558CTD
71Myoglobin blood increasedOFFSIDES
72Myoglobin urine presentOFFSIDES
73Nephritis, Interstitial12372954CTD
74Neutrophil count abnormalOFFSIDES
75Parkinsonian Disorders1567736CTD
76PolyneuropathyOFFSIDES
77PolyuriaOFFSIDES
78PoriomaniaOFFSIDES
79Prinzmetal's variant angina15222138CTD
80Pulmonary HypertensionOFFSIDES
81Pulmonary InfarctionOFFSIDES
82RalesOFFSIDES
83Renal Insufficiency12372954CTD
84Respiratory FailureOFFSIDES
85Retinal Vein Occlusion12372954CTD
86RhabdomyolysisOFFSIDES
87Sick Sinus SyndromeOFFSIDES
88Skin tightnessOFFSIDES
89Sudden deathOFFSIDES
90Tachycardia6167799CTD
91Therapy non-responderOFFSIDES
92Thrombotic strokeOFFSIDES
93Tongue bitingOFFSIDES
94Unevaluable eventOFFSIDES
95Urine output increasedOFFSIDES
96Vascular calcificationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.